These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25642761)

  • 1. Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.
    Passweg JR; Baldomero H; Bader P; Bonini C; Cesaro S; Dreger P; Duarte RF; Dufour C; Falkenburg JH; Farge-Bancel D; Gennery A; Kröger N; Lanza F; Nagler A; Sureda A; Mohty M;
    Bone Marrow Transplant; 2015 Apr; 50(4):476-82. PubMed ID: 25642761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation.
    Passweg JR; Baldomero H; Peters C; Gaspar HB; Cesaro S; Dreger P; Duarte RF; Falkenburg JH; Farge-Bancel D; Gennery A; Halter J; Kröger N; Lanza F; Marsh J; Mohty M; Sureda A; Velardi A; Madrigal A;
    Bone Marrow Transplant; 2014 Jun; 49(6):744-50. PubMed ID: 24637898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.
    Passweg JR; Baldomero H; Bader P; Bonini C; Cesaro S; Dreger P; Duarte RF; Dufour C; Kuball J; Farge-Bancel D; Gennery A; Kröger N; Lanza F; Nagler A; Sureda A; Mohty M
    Bone Marrow Transplant; 2016 Jun; 51(6):786-92. PubMed ID: 26901709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EBMT activity survey: 1990-2010.
    Passweg JR; Baldomero H; Gratwohl A; Bregni M; Cesaro S; Dreger P; de Witte T; Farge-Bancel D; Gaspar B; Marsh J; Mohty M; Peters C; Tichelli A; Velardi A; de Elvira CR; Falkenburg F; Sureda A; Madrigal A;
    Bone Marrow Transplant; 2012 Jul; 47(7):906-23. PubMed ID: 22543746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic SCT in Europe: data and trends in 2011.
    Passweg JR; Baldomero H; Bregni M; Cesaro S; Dreger P; Duarte RF; Falkenburg JH; Kröger N; Farge-Bancel D; Gaspar HB; Marsh J; Mohty M; Peters C; Sureda A; Velardi A; Ruiz de Elvira C; Madrigal A;
    Bone Marrow Transplant; 2013 Sep; 48(9):1161-7. PubMed ID: 23584439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products.
    Gratwohl A; Baldomero H; Frauendorfer K; Rocha V; Apperley J; Niederwieser D; ;
    Bone Marrow Transplant; 2008 Apr; 41(8):687-705. PubMed ID: 18084334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.
    Passweg JR; Baldomero H; Bader P; Bonini C; Duarte RF; Dufour C; Gennery A; Kröger N; Kuball J; Lanza F; Montoto S; Nagler A; Snowden JA; Styczynski J; Mohty M
    Bone Marrow Transplant; 2017 Jun; 52(6):811-817. PubMed ID: 28287639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
    Giebel S; Boumendil A; Labopin M; Seesaghur A; Baron F; Ciceri F; Esteve J; Gorin NC; Savani B; Schmid C; Wetten S; Mohty M; Nagler A
    Ann Hematol; 2019 Oct; 98(10):2389-2398. PubMed ID: 31392462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors.
    Cairo MS; Rocha V; Gluckman E; Hale G; Wagner J
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):44-53. PubMed ID: 18162220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group.
    Mohamed SY; Fadhil I; Hamladji RM; Hamidieh AA; Fahmy O; Ladeb S; Alimoghaddam K; Elhaddad A; Nacer RA; Alsharif F; Rasheed W; Jahani M; Mousavi SA; Alseraihy A; Abdel-Rahman F; Al Jefri A; Hussein AA; Alabdulaaly A; Ibrahim A; Bekadja MA; Abboud M; Ahmed P; Dennison D; Bakr M; Benchekroun S; Hussain F; Othman TB; Aljurf M; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2011; 4(2):81-93. PubMed ID: 21727769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
    Gluckman E; Cappelli B; Scigliuolo GM; De la Fuente J; Corbacioglu S
    Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):181-188. PubMed ID: 32201153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012.
    Correa C; Gonzalez-Ramella O; Baldomero H; Basquiera AL; Baena R; Arcuri L; Puga B; Rosales C; Chávez M; Hernández C; Maldonado B; Gómez-De León A; Mendoza N; Frutos C; Aranda L; Díaz L; Hernández M; Seber A; Karduss A; Jaimovich G; Martínez-Rolon J; Bonfim C; Greinix H; Koh MBC; Aljurf M; Iida M; Saber W; Niederwieser D; Atsuta Y; Galeano S; ;
    Bone Marrow Transplant; 2022 Jun; 57(6):881-888. PubMed ID: 35347244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
    Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
    Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
    Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.
    González-Vicent M; Molina B; Andión M; Sevilla J; Ramirez M; Pérez A; Díaz MA
    Eur J Haematol; 2011 Jul; 87(1):46-53. PubMed ID: 21692851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
    Gratwohl A; Baldomero H; Schmid O; Horisberger B; Bargetzi M; Urbano-Ispizua A
    Bone Marrow Transplant; 2005 Oct; 36(7):575-90. PubMed ID: 16086045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease.
    Fitzhugh CD; Abraham A; Hsieh MM
    Adv Exp Med Biol; 2017; 1013():123-153. PubMed ID: 29127679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies.
    Gratwohl A; Baldomero H; Schwendener A; Rocha V; Apperley J; Frauendorfer K; Niederwieser D; ;
    Bone Marrow Transplant; 2009 Feb; 43(4):275-91. PubMed ID: 19169283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors.
    Marks DI; Woo KA; Zhong X; Appelbaum FR; Bachanova V; Barker JN; Brunstein CG; Gibson J; Kebriaei P; Lazarus HM; Olsson R; Perales MA; Pidala J; Savani B; Rocha V; Eapen M
    Haematologica; 2014 Feb; 99(2):322-8. PubMed ID: 24056817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey.
    Gratwohl A; Baldomero H; Passweg J; Urbano-Ispizua A;
    Bone Marrow Transplant; 2002 Dec; 30(12):813-31. PubMed ID: 12476273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.